Wednesday, February 4, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Offer Varied Perspectives on Sweetgreens Stock Performance

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
FLO stock news
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Analyst Brian Harbour from Morgan Stanley has reiterated his Underweight rating on Sweetgreen (NYSE: SG) but has raised the price target to $11, reflecting his assessment of the company’s potential. Meanwhile, analyst Brian Mullan of Piper Sandler has increased the price target by 18.8% to $19, citing better than expected revenue and margins. In a separate update, Brian Harbour also maintained an Equal-Weight rating on Sweetgreen with a $14 price target. These analysts’ actions offer valuable perspectives on Sweetgreen’s stock performance and future outlook in the market.

___

Date: March 2, 2024

SG Stock Soars 28.41% on March 2, 2024: Positive Price Momentum Ahead?

On March 2, 2024, SG stock had an impressive performance, with the price of shares increasing by $3.62 since the market last closed, representing a significant 28.41% rise, closing at $16.36. Additionally, in after-hours trading, the stock continued to climb, rising by an additional $0.13.

One notable aspect of SG’s performance is its price momentum. The stock is currently trading near the top of its 52-week range and above its 200-day simple moving average, which is a bullish signal for investors.

Investors may be taking note of SG’s strong performance and positive price momentum. It will be interesting to see if SG can sustain this momentum in the days and weeks ahead.

As always, investors should conduct their own research and consider their investment goals and risk tolerance before making any decisions. Stock prices can be volatile, and past performance is not necessarily indicative of future results. However, based on the data provided by CNN Money, SG’s performance on March 2, 2024, is certainly worth keeping an eye on.

SG Stock Performance Analysis: Revenue and Net Income Improvements in 2024

On March 2, 2024, SG stock had a mixed performance based on the financial data provided by CNN Money. The company’s total revenue for the past year was $584.04 million, which represented a 24.24% increase from the previous year. However, in the fourth quarter, the total revenue was $153.03 million, which remained flat compared to the previous quarter.

In terms of net income, SG reported a loss of $113.38 million for the past year, which was a 40.46% improvement from the previous year. In the fourth quarter, the net income was -$27.41 million, showing no change from the previous quarter.

Earnings per share (EPS) for SG stock were -$1.01 for the past year, which was a 41.41% increase from the previous year. In the fourth quarter, the EPS was -$0.24, which also remained flat compared to the previous quarter.

Overall, SG stock showed improvements in net income and EPS compared to the previous year. However, the flat total revenue in the fourth quarter might have impacted investor confidence in the short term. Investors should keep an eye on any updates or announcements from SG to make informed decisions about their investments.

Tags: SG
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

JMP Securities Analyst Initiates Coverage on Acrivon Therapeutics with Market Outperform Rating and 14 Target Price

Technology Data analytics stock Trading

Title Bearish Sentiment Grows for Arista Networks NYSEANET as Unusual Options Activity Surges

Retail Market Capitalization

UBS Analyst Maintains Neutral Rating on Best Buy Co with Increased Price Target

Recommended

Disappointing Results of Nonclinical PreIND Study for Ampios OA201

2 years ago
Nestle Stock

Leadership Turmoil at Nestlé Sparks Strategic Uncertainty

5 months ago
Wabtec Stock

Wabtec Shares Maintain Upward Momentum with Strong Quarterly Performance

3 months ago
Bloom Energy Stock

Bloom Energy Shares Face Pressure as Company Insiders Cash Out

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Terawulf Expands Infrastructure Portfolio with Major Site Acquisitions

QuantumScape Investors Await Critical Milestones After Share Price Decline

Chevron Shares Maintain Momentum Amid Record Production and Dividend Growth

UBS Shares Slide Despite Strong Earnings: A Closer Look at Investor Concerns

Can Midnight’s Privacy Push Revive Cardano’s Stagnant Valuation?

Defense Sector Spotlight: EOS Positioned Amid Rising Drone Threats and European Rearmament

Trending

National Healthcare Stock
Earnings

National Healthcare’s Financial Report: A Crucial Test Approaches

by Dieter Jaworski
February 4, 2026
0

Investors are marking their calendars for a pivotal date in late February 2026. National Healthcare is poised...

XRP Stock

XRP’s Dual Milestone: Regulatory Green Light Meets Core Protocol Upgrade

February 4, 2026
Coinbase Stock

Coinbase Faces Mounting Pressure from Legal and Reputational Challenges

February 4, 2026
Terawulf Stock

Terawulf Expands Infrastructure Portfolio with Major Site Acquisitions

February 4, 2026
QuantumScape Stock

QuantumScape Investors Await Critical Milestones After Share Price Decline

February 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • National Healthcare’s Financial Report: A Crucial Test Approaches
  • XRP’s Dual Milestone: Regulatory Green Light Meets Core Protocol Upgrade
  • Coinbase Faces Mounting Pressure from Legal and Reputational Challenges

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com